Skip to main content

Table 1 A summary of the data in Table 1, by continent and an overall global estimate of COPD prevalence, hospitalisation rate, IA prevalence in COPD and associated mortality

From: The global impact of Aspergillus infection on COPD

Region Population size [16] COPD population GOLD stages II-IV COPD annual hospitalisation rate [18] IA annual rate [10, 20] IA mortality rate [10, 20] IA annual incidence per 100,000 population
n (% of population) 10.5% of COPD population 1.30–3.90% of COPD hospitalisation rate n (% of IA cases)
Africa 1,197,415,000 64,298,051 (5.37) 6,751,295 87,767 1.3% 62,929 71.7% 7.3
271,877 3.9% 115,996 43.0% 22.7
America 1,001,386,000 85,278,783 (8.52) 8,954,272 116,406 1.3% 83,463 71.7% 11.6
349,217 3.9% 150,163 43.0% 34.9
Asia 4,476,519,000 339,206,893 (8.58) 35,616,724 462,894 1.3% 331,895 71.7% 10.3
1,389,052 3.9% 597,292 43.0% 31.0
Europe 765,958,000 59,484,329 (7.77) 6,245,855 81,196 1.3% 58,218 71.7% 10.6
247,744 3.9% 106,530 43.0% 32.3
Oceania 37,131,000 4,032,543 (10.86) 423,417 5504 1.3% 3947 71.7% 14.8
16,513 3.9% 7101 43.0% 44.5
Globally 7,478,409,000 552,300,599 (7.39) 57,991,563 753,073 1.3% 540,451 71.7% 10.0
2,272,322 3.9% 977,082 43.0% 30.40